scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.VIROL.2016.06.019 |
P698 | PubMed publication ID | 27449478 |
P50 | author | Inam Ullah Khan | Q84060205 |
P2093 | author name string | Rui Liu | |
Yan Yang | |||
Jingbo Wang | |||
Naishuo Zhu | |||
P2860 | cites work | Estimating the global burden of endemic canine rabies | Q21090117 |
Antigen presentation and T cell stimulation by dendritic cells | Q22255632 | ||
Toll-like receptors in antiviral innate immunity | Q27011462 | ||
TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta | Q28506630 | ||
Programming the magnitude and persistence of antibody responses with innate immunity | Q30400144 | ||
TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice | Q30419734 | ||
Rabies virus infection induces type I interferon production in an IPS-1 dependent manner while dendritic cell activation relies on IFNAR signaling | Q33641422 | ||
Characterization of a single-cycle rabies virus-based vaccine vector | Q33676502 | ||
Increased MDSC accumulation and Th2 biased response to influenza A virus infection in the absence of TLR7 in mice | Q34038100 | ||
Activation of NF-κB via endosomal Toll-like receptor 7 (TLR7) or TLR9 suppresses murine herpesvirus 68 reactivation | Q34059398 | ||
Synthesis and immunological characterization of toll-like receptor 7 agonistic conjugates | Q34291783 | ||
Expression of interferon gamma by a recombinant rabies virus strongly attenuates the pathogenicity of the virus via induction of type I interferon. | Q34992598 | ||
The TLR7 agonist induces tumor regression both by promoting CD4⁺T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells | Q35176439 | ||
Viremic HIV Controllers Exhibit High Plasmacytoid Dendritic Cell-Reactive Opsonophagocytic IgG Antibody Responses against HIV-1 p24 Associated with Greater Antibody Isotype Diversification | Q35823060 | ||
A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms | Q35895400 | ||
rIL-22 as an adjuvant enhances the immunogenicity of rGroEL in mice and its protective efficacy against S. Typhi and S. Typhimurium | Q36302839 | ||
Toll-like receptor 7 mediates early innate immune responses to malaria | Q37336051 | ||
Toll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice. | Q37712843 | ||
The immune response to rabies virus infection and vaccination | Q37724483 | ||
The role of toll-like receptors in the induction of immune responses during rabies virus infection. | Q37877955 | ||
Innate antiviral signalling in the central nervous system | Q38169444 | ||
Toll-like receptor signaling pathways | Q38259564 | ||
siRNA-induced immunostimulation through TLR7 promotes antitumoral activity against HPV-driven tumors in vivo. | Q39572943 | ||
A novel rabies virus lipopeptide provides a better protection by improving the magnitude of DCs activation and T cell responses. | Q39764413 | ||
Humoral immunity. Apoptosis and antigen affinity limit effector cell differentiation of a single naïve B cell | Q40019887 | ||
Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. | Q40416432 | ||
A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge | Q40824269 | ||
Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides | Q41099515 | ||
Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes | Q45184856 | ||
A CpG oligodeoxynucleotide acts as a potent adjuvant for inactivated rabies virus vaccine | Q45396680 | ||
The history of Toll-like receptors - redefining innate immunity. | Q46240771 | ||
Liposomes containing NY‑ESO‑1/tetanus toxoid and adjuvant peptides targeted to human dendritic cells via the Fc receptor for cancer vaccines. | Q51075893 | ||
Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses. | Q51991421 | ||
Critical role of IkappaB Kinase alpha in TLR7/9-induced type I IFN production by conventional dendritic cells. | Q54689085 | ||
TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses | Q79717981 | ||
TLR9 signaling in B cells determines class switch recombination to IgG2a | Q79718037 | ||
TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation | Q83226449 | ||
TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface | Q85831264 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | rabies | Q39222 |
toll-like receptor | Q408004 | ||
rabies virus | Q698976 | ||
P1104 | number of pages | 9 | |
P304 | page(s) | 102-110 | |
P577 | publication date | 2016-07-21 | |
P1433 | published in | Virology | Q7934867 |
P1476 | title | Rabies virus lipopeptide conjugated to a TLR7 agonist improves the magnitude and quality of the Th1-biased humoral immune response in mice | |
P478 | volume | 497 |
Q40086752 | Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model |
Q91808429 | Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines |
Q64114489 | Toll-Like Receptor 7 Enhances Rabies Virus-Induced Humoral Immunity by Facilitating the Formation of Germinal Centers |
Search more.